Answers are grounded in this paper and cite their sources.
Despite the well-established roles of long-chain fatty acids in animal and human metabolism, the involvement of their hydroxylated metabolites in carcinogenesis remains unclear, primarily due to the lack of robust quantitative analytical methods. In this study, we present a novel analytical approach that enables the quantification of cis- and trans-isomers of long-chain fatty acids and their hydroxylated metabolites in tumor and non-tumor colorectal tissues of mice. Using a combination of liquid chromatography, differential mobility spectrometry, and tandem mass spectrometry (LC-DMS-MS/MS), we achieved the separation and quantification of a diverse range of free fatty acids, including nine saturated, eleven monounsaturated, six polyunsaturated, four carboxylated, and nine hydroxylated fatty acids, covering various degrees of saturation and isomerism. The method was validated with deuterated and 13 C-labelled isotopologs of non-hydroxylated fatty acids. Our comparative analysis of tumor and non-tumor colorectal tissues from mice revealed distinctive alterations in the profiles of individual analytes, particularly regarding the long-chain polyunsaturated fatty acid C20:4 and its hydroxylated metabolites C20:4-5-OH and C20:4-12-OH. These characteristic differences in concentration will enable novel insights into the potential involvement of specific long-chain hydroxylated fatty acids in the pathogenesis of colorectal tumors.
No takes yet. Share an insight, caveat, or question.
Wimmer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: